Screening of Lipid Carriers and Characterization of Drug-Polymer-Lipid Interactions for the Rational Design of Polymer-Lipid Hybrid Nanoparticles (PLN)

PurposeThe thermodynamics and solid state properties of components and their interactions in a formulation for polymer-lipid hybrid nanoparticles (PLN) were characterized for screening lead lipid carriers and rational design of PLN.MethodsVerapamil HCl (VRP) was chosen as a model drug and dextran sulfate sodium (DS) as a counter-ionic polymer. Solubility parameters of VRP, VRP-DS complex, and various lipids were calculated and partition of VRP and VRP-DS in lipids was determined. Thermodynamics of VRP binding to DS was determined by isothermal titration calorimetry (ITC). The solid state properties of individual components and their interactions were characterized using differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD).ResultsDodecanoic acid (DA) was identified as the best lipid carrier among all lipids tested based on the solubility parameters and partition coefficients. VRP-DS complexation was a thermodynamically favorable process. Maximum binding capacity of DS and the highest drug loading capacity of DA were obtained at an equal ionic molar ratio of DS to VRP. In the PLN formulation, DA remained its crystal structure but had a slightly lower melting point, while VRP-DS complex was in an amorphous form.ConclusionsDrug loading efficiency and capacity of a lipid matrix depend on the VRP-DS binding and the interactions of the complex with the lipid. A combined analysis of solubility parameters and partition coefficients is useful for screening lipid candidates for PLN preparation.

[1]  R. Cavalli,et al.  Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair , 1995 .

[2]  R. Müller,et al.  Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles , 1996 .

[3]  H. Bosshard,et al.  Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition , 1999, Journal of molecular recognition : JMR.

[4]  R. Müller,et al.  Solid lipid nanoparticles (SLN) for controlled drug delivery , 1996 .

[5]  R. Rowe.  Interaction of lubricants with microcrystalline cellulose and anhydrous lactose — a solubility parameter approach , 1988 .

[6]  R. Müller,et al.  Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[7]  Sabiruddin Mirza,et al.  Physical solid-state properties and dissolution of sustained-release matrices of polyvinylacetate. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  R. Rowe.  Polar/non-polar interactions in the granulation of organic substrates with polymer binding agents , 1989 .

[9]  R. F. Fedors,et al.  A method for estimating both the solubility parameters and molar volumes of liquids , 1974 .

[10]  R. Müller,et al.  Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization , 1994 .

[11]  M. Lück,et al.  Partial solubility parameters of poly(D,L-lactide-co-glycolide). , 2004, International journal of pharmaceutics.

[12]  N. A. Santagati,et al.  Inclusion Complexation of 4-Biphenylacetic Acid with β-Cyclodextrin , 1990 .

[13]  S. Gohla,et al.  Comparison of wax and glyceride solid lipid nanoparticles (SLN). , 2000, International journal of pharmaceutics.

[14]  K. Mäder,et al.  Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.

[15]  R. Müller,et al.  Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  R. Cavalli,et al.  Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN). , 1999, Pharmacological research.

[17]  S. Furlanetto,et al.  Utilization of differential scanning calorimetry as a screening technique to determine the compatibility of ketoprofen with excipients , 1995 .

[18]  Peter York,et al.  The use of solubility parameters in pharmaceutical dosage form design , 1997 .

[19]  P York,et al.  Solubility parameters as predictors of miscibility in solid dispersions. , 1999, Journal of pharmaceutical sciences.

[20]  Sevim Z. Erhan,et al.  A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells , 2006, Pharmaceutical Research.

[21]  R. Müller,et al.  Solid lipid nanoparticles (SLN) : an alternative colloidal carrier system for controlled drug delivery , 1995 .

[22]  N. Taulier,et al.  Association of the minor groove binding drug Hoechst 33258 with d(CGCGAATTCGCG)2: volumetric, calorimetric, and spectroscopic characterizations. , 2005, Biochemistry.

[23]  H. Bunjes,et al.  Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential , 1997 .

[24]  C. Hansen,et al.  The three dimensional solubility parameter - key to paint component affinities: I. Solvents, plasticizers, polymers, and resins , 1967 .

[25]  R. Cavalli,et al.  Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. , 2002, International journal of pharmaceutics.

[26]  R. Müller,et al.  Solid lipid nanoparticles for parenteral drug delivery. , 2004, Advanced drug delivery reviews.

[27]  X. Wu,et al.  Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers. , 2004, Journal of pharmaceutical sciences.